Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Contracept Reprod Health Care ; 26(4): 326-333, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33871288

ABSTRACT

OBJECTIVES: The Contraceptive Counselling (COCO) study tested whether a structured approach to assessing patient needs and expectations improved method choice and satisfaction with the contraceptive decision-making process. METHODS: Physicians and women were invited to complete needs-based contraceptive counselling sessions using a structured questionnaire. Physicians recorded the individual responses online; women evaluated the process using an immediate post-consultation questionnaire and then via a structured online interview 6 months later. RESULTS: A total of 92 gynaecologists and 1176 women participated: 951 women completed the immediate post-consultation survey and 145 took part in the 6 month online evaluation. There was a substantial increase in satisfaction with the current contraceptive method: the number of women reporting they were 'very satisfied' with their contraceptive method increased by 30%. This applied to starters and switchers as well as to women continuing with their previous method. Women were highly satisfied with the structured approach; 95% rated the counselling as 'good' or 'very good' and 'comprehensive and detailed'. CONCLUSION: Using a structured approach to share information tailored to women's needs can help them choose from a broader range of methods and, in some cases, change to a method more suitable to their individual needs, and ultimately increase satisfaction with their choice.


Subject(s)
Contraception , Counseling/methods , Decision Making, Shared , Patient Participation , Patient-Centered Care , Physicians/psychology , Adult , Contraceptive Agents , Contraceptive Devices , Decision Making , Female , Gynecology , Humans , Middle Aged , Patient Preference
2.
Physiol Biochem Zool ; 83(5): 733-52, 2010.
Article in English | MEDLINE | ID: mdl-20565233

ABSTRACT

Many invertebrates and ectothermic vertebrates successfully cope with a fluctuating supply of ambient oxygen-and consequently, a highly variable tissue oxygenation-through increasing their antioxidant barriers. During chronic deprivation of oxygen, however, the hypometabolic defense mode of the fruit fly Drosophila, the hypoxia-induced behavioral hypothermia of the crayfish Pacifastacus leniusculus, and the production of ethanol during anoxia by the crucian carp Carassius carassius all indicate that these animals are also capable of utilizing a suite of genetic and physiological defenses to survive otherwise lethal reductions in tissue oxygenation. Normally, much of an organism's gene response to hypoxia is orchestrated via the hypoxia-inducible transcription factor HIF. Recent developments expand our view of HIF function even further by highlighting regulatory roles for HIF in the hypometabolism of insects, in the molting and the normoxic immune response of crustaceans, and in the control-via the downstream effector gene erythropoietin-of the hypoxic ventilatory response and pulmonary hypertension in mammals. These and related topics were collectively presented by the authors in a symposium of the 2008 ICA-CBP conference at Mara National Reserve, Kenya, Africa. This synthesis article communicates the essence of the symposium presentations to the wider community.


Subject(s)
Adaptation, Physiological/physiology , Hypoxia-Inducible Factor 1/metabolism , Hypoxia/physiopathology , Oxidative Stress/physiology , Oxygen/metabolism , Animals , Energy Metabolism/physiology , Immunity, Innate/physiology , Pulmonary Ventilation/physiology , Species Specificity , Temperature
3.
Gen Physiol Biophys ; 27(2): 127-42, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18645228

ABSTRACT

S100A1 is a Ca(2+)-binding protein and predominantly expressed in the heart. We have generated a mouse line of S100A1 deficiency by gene trap mutagenesis to investigate the impact of S100A1 ablation on heart function. Electrocardiogram recordings revealed that after beta-adrenergic stimulation S100A1-deficient mice had prolonged QT, QTc and ST intervals and intraventricular conduction disturbances reminiscent of 2 : 1 bundle branch block. In order to identify genes affected by the loss of S100A1, we profiled the mutant and wild type cardiac transcriptomes by gene array analysis. The expression of several genes functioning to the electrical activity of the heart were found to be significantly altered. Although the default prediction would be that mRNA and protein levels are highly correlated, comprehensive immunoblot analyses of salient up- or down-regulated candidate genes of any cellular network revealed no significant changes on protein level. Taken together, we found that S100A1 deficiency results in cardiac repolarization delay and alternating ventricular conduction defects in response to sympathetic activation accompanied by a significantly different transcriptional regulation.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Heart/physiology , S100 Proteins/physiology , Adrenergic alpha-Agonists/pharmacology , Animals , Dobutamine/pharmacology , Electrocardiography , Gene Expression Profiling , Heart Conduction System/drug effects , Isoproterenol/pharmacology , Mice , Mice, Knockout , Myocardium/metabolism , Norepinephrine/pharmacology , Oligonucleotide Array Sequence Analysis , S100 Proteins/genetics , Ventricular Function, Left/drug effects , Ventricular Pressure/drug effects
4.
Pflugers Arch ; 446(4): 437-46, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12733076

ABSTRACT

Continuous i.v. infusion of norepinephrine in rats has been shown to induce early interleukin (IL)-6 mRNA expression in the left ventricle (LV) which was followed by hypertrophy and fibrosis. In this study, two approaches were used. In the first, NE (0.1 mg/kg per hour) was infused i.v. in rats for several time periods, and freshly obtained ventricular myocardium was dissociated into myocyte (MC) and non-myocyte (NMC) fractions. Second, isolated adult MCs and fibroblasts were treated with NE (10 microM). NE infusion (4 h, in vivo) caused an 11-fold increase in IL-6 mRNA in both cell populations. In vitro treatment of isolated adult MCs for 2 h and of fibroblasts for 1 h with NE induced a 3.5- and 23-fold maximum increase, respectively, in IL-6 mRNA. After in vivo NE treatment, the expression of the mRNA of the transcriptional factor of IL-6, C/EBP-beta, was elevated earlier (after 45 min of NE infusion) than IL-6 mRNA (after 4 h) and was seen in MCs and NMCs. The mRNAs of both receptors of IL-6, the soluble IL6R and gp130, were increased subsequently to IL-6 mRNA. Gp130 was elevated after 24 h and, like IL6R, predominantly in NMCs. In contrast, the IL6R protein and the downstream regulator STAT3 were increased only in MCs after 24 h of NE infusion. The mRNA of C/EBP-delta, which is regulated by STAT3, was elevated only in myocytes.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Interleukin-6/genetics , Myocytes, Cardiac/physiology , Norepinephrine/pharmacology , Signal Transduction/drug effects , Animals , Antigens, CD/genetics , CCAAT-Enhancer-Binding Proteins/genetics , CCAAT-Enhancer-Binding Proteins/metabolism , Cytokine Receptor gp130 , DNA-Binding Proteins/metabolism , Female , Fibroblasts/physiology , Gene Expression/drug effects , Interleukin-6/metabolism , Membrane Glycoproteins/genetics , Phosphorylation , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptors, Interleukin-6/genetics , Receptors, Interleukin-6/metabolism , STAT3 Transcription Factor , Trans-Activators/metabolism
5.
Cardiovasc Res ; 52(2): 265-73, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11684074

ABSTRACT

OBJECTIVE: In this study we have tested the hypothesis that degradation of collagen by matrix metalloproteinase 2 (MMP-2) precedes the deposition of extracellular matrix (ECM) after long term norepinephrine (NE) treatment. METHODS: Female Sprague-Dawley rats received continuous i.v. infusion of NE (0.1 mg/kg.h) for 1, 2, 3, 4 and 14 days. Heart function and weight as well as expression of cardiac colligin and of collagen I and III were examined. Furthermore, we have assessed the degradation pathway of collagen by measuring the mRNA and activity of myocardial MMP-2 and tissue inhibitor of metalloproteinase 2 (TIMP-2) as well as the protein level of TIMP-2. RESULTS: NE induced hypertrophy predominantly of the left ventricle (LV) in a time-dependent manner. It increased the mRNAs of colligin, collagen I and III, and of MMP-2 and TIMP-2 as well as MMP-2 activity in two phases: In the initial phase, at 3 and 4 days, the mRNA of colligin and of collagen I and III was elevated predominantly in the LV, MMP-2 and TIMP-2 mRNA, as well as TIMP-2 protein and MMP-activity were increased in both ventricles. The second phase, after 14 days, was characterized by a less pronounced increase in colligin, collagen I and III and in MMP-2 activity which occurred exclusively in the LV. Finally, long-term treatment with NE induced a 37% increase in interstitial fibrosis which was shown to occur exclusively in the LV after 14 days. CONCLUSION: NE treatment induced fibrosis exclusively in the LV which was associated with hypertrophy predominantly of the LV. The elevated MMP-2 activity seems to be necessary for the ECM to adapt to the enlargement of myocytes and to reduce overproduction of collagen.


Subject(s)
Extracellular Matrix/metabolism , Hypertrophy, Left Ventricular/metabolism , Matrix Metalloproteinase 2/metabolism , Myocardium/metabolism , Norepinephrine/pharmacology , Tissue Inhibitor of Metalloproteinase-2/metabolism , Adrenergic Antagonists/pharmacology , Analysis of Variance , Animals , Blotting, Western , Calcium Channel Blockers/pharmacology , Carbazoles/pharmacology , Carvedilol , Collagen Type I/metabolism , Collagen Type III/metabolism , Electrophoresis, Polyacrylamide Gel , Female , Fibrosis , Gene Expression/drug effects , Hypertrophy, Left Ventricular/pathology , Infusions, Intravenous , Matrix Metalloproteinase 2/genetics , Nisoldipine/pharmacology , Propanolamines/pharmacology , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Time Factors , Tissue Inhibitor of Metalloproteinase-2/genetics , Ventricular Remodeling
6.
J Mol Cell Cardiol ; 33(6): 1191-207, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11444923

ABSTRACT

Extensive myocardial remodeling occurs after transmural myocardial infarction (MI). The infarcted myocardium is being replaced by scar tissue after gradual resorption of the necrotic tissue. The remodeling process involves both synthesis and degradation of collagens as major components of the extracellular matrix (ECM). In the present study we have analyzed the time-dependent changes of the processes related to this fibrosis in the infarct area and in the non-infarcted left ventricle (LV) six hours to 82 days after occlusion of the left anterior descending coronary artery (LAD) in rats. We also examined whether changes occurred in the expression pattern of the transforming growth factor (TGF) beta isoforms, since this cytokine is known as powerful inductor of fibrosis. Elevation in colligin expression preceded the pronounced increase in mRNA expression of both type I and type III collagen after MI from day three onwards. The maximal increase in colligin protein in the infarct area coincided with the most pronounced expression of collagen I and collagen III mRNA expression. Also, the expression and activity of matrix metalloproteinases (MMPs) and of tissue inhibitor of matrix metalloproteinase (TIMP)-2 mRNA were increased predominantly in the infarct area. TGF beta(1)and TGF-beta(2)expression increased within the first days after MI, whereas TGF-beta(3)expression was elevated predominantly in the infarct area. This pronounced increase in TGF-beta(3)persisted up to 82 days and correlated positively with the parameters of ECM metabolism. Thus, the scar formation is an ongoing dynamic process in which TGF-beta(3)seems to play an active role in the complex ventricular remodeling.


Subject(s)
Extracellular Matrix/metabolism , Gene Expression , Myocardial Infarction/metabolism , Myocardium/metabolism , Transforming Growth Factor beta/genetics , Animals , Arteries , Carrier Proteins/genetics , Carrier Proteins/metabolism , Collagen/genetics , Coronary Vessels , Female , Gelatin/metabolism , Glycoproteins , Hemodynamics , Hypertrophy, Right Ventricular/metabolism , Hypertrophy, Right Ventricular/physiopathology , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 8/genetics , Matrix Metalloproteinase 8/metabolism , Matrix Metalloproteinase 9/genetics , Matrix Metalloproteinase 9/metabolism , Myocardial Infarction/physiopathology , Protein Isoforms/genetics , RNA, Messenger , Rats , Rats, Sprague-Dawley , Tissue Inhibitor of Metalloproteinase-2/genetics , Transforming Growth Factor beta1 , Transforming Growth Factor beta2 , Transforming Growth Factor beta3 , Ventricular Dysfunction, Left/metabolism , Ventricular Dysfunction, Left/physiopathology , Ventricular Dysfunction, Right/metabolism , Ventricular Dysfunction, Right/physiopathology
7.
Am J Physiol Heart Circ Physiol ; 281(1): H14-21, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11406463

ABSTRACT

Proinflammatory cytokines have been implicated in the pathophysiology of different heart diseases. Recent evidence suggests that interleukin-6 (IL--6) may play a role in mechanisms leading to cardiac hypertrophy. In addition, catecholamines are known to induce cardiac hypertrophy. In the present study, we examined whether cardiac fibroblasts may be a potential source of IL--6 production in the rat heart and whether catecholamines can modulate the IL--6 synthesis. Only a small amount of IL--6 mRNA was detected in unstimulated rat cardiac fibroblasts. However, a 50-fold increase of IL--6 mRNA was found after stimulation with norepinephrine (NE). Addition of carvedilol, a alpha- and beta-adrenergic receptor antagonist, prevented almost completely the NE-induced synthesis of IL--6 mRNA. Phenylephrine, an alpha-adrenergic agonist, and isoproterenol, a beta-adrenergic agonist, also induced an increase in IL--6. However, the stimulation via beta-receptors led to a more pronounced elevation. These data show that NE increases IL--6 expression in rat cardiac fibroblasts and that IL--6 may play an important autocrine/paracrine role in cardiac disease states associated with hypertrophy.


Subject(s)
Fibroblasts/drug effects , Fibroblasts/metabolism , Interleukin-6/biosynthesis , Myocardium/metabolism , Norepinephrine/pharmacology , Animals , Cells, Cultured , Cytokines/genetics , Female , Fibroblasts/physiology , Gene Expression/drug effects , Interleukin-6/genetics , Myocardium/cytology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology
8.
J Mol Cell Cardiol ; 32(2): 273-84, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10722803

ABSTRACT

Continuous intravenous infusion of norepinephrine norepinephrine (NE, 0.1 mg/kg/h) induced hypertrophy of the left ventricle (LV), but not of the right ventricle (RV) in rats, although RV systolic pressure (RVSP) was much more elevated than LVSP. After NE infusion, there was a time-dependent (20 min to 72 h) expression in the mRNA of interleukin (IL)-6 and IL-1 beta. The expression of IL-6 increased markedly and reached the maximum after 4 h with an 80-fold elevation. In the RV, the expression increased only 20-fold. The mRNA of IL-1 beta increased significantly after NE stimulation only in the LV and reached the maximum after 12 h with a 12-fold elevation. After 12 h of NE infusion, colligin mRNA was elevated for the first time with further progression until 72 h. The six-fold abundance of colligin mRNA seen after 72 h was significantly higher in the LV than in the RV. A similar increase was observed on the protein level (Western blotting). The expression of collagen I and III increased significantly after 24 h only in the LV. After 72 h, the mRNA expression of collagen I was increased 16-fold and that of collagen III 10-fold. This expression was significantly higher than that in the RV. Also the elevation in atrial natriuretic peptide (ANP) mRNA started earlier and was more pronounced in the LV than in the RV. The alpha- and beta-adrenergic receptor blocker carvedilol normalized all functional parameters after 6 h and 72 h and prevented the development of LV hypertrophy that occurred after 72 h. The NE-induced increased expression of the mRNAs studied was either prevented (IL-6, IL-1 beta ) or attenuated (colligin, collagen I and III, ANP) by combined alpha- and beta-receptor blockade. The elevation of afterload which was associated with the NE effect was normalized by the calcium-channel blocker nisoldipin, but NE-induced LV hypertrophy and the increase in ANP and collagen mRNA were not affected.


Subject(s)
Collagen/biosynthesis , Cytokines/biosynthesis , Gene Expression Regulation/drug effects , Hypertrophy, Left Ventricular/chemically induced , Muscle Proteins/biosynthesis , Norepinephrine/pharmacology , Ventricular Remodeling/drug effects , Adrenergic Antagonists/pharmacology , Animals , Atrial Natriuretic Factor/biosynthesis , Atrial Natriuretic Factor/genetics , Calcium Channel Blockers/pharmacology , Carbazoles/pharmacology , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Carvedilol , Collagen/genetics , Cytokines/genetics , Female , Glycoproteins , Hemodynamics/drug effects , Hypertrophy, Left Ventricular/genetics , Hypertrophy, Left Ventricular/metabolism , Hypertrophy, Left Ventricular/pathology , Interleukin-1/biosynthesis , Interleukin-1/genetics , Interleukin-6/biosynthesis , Interleukin-6/genetics , Muscle Proteins/genetics , Nisoldipine/pharmacology , Propanolamines/pharmacology , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Ventricular Remodeling/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...